Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 109

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 109
---
 |                                                                       | 980,085 |     |                                                                                            | - |     | $                           | 5.02 |     |                        | 8/27/34 |     |                                                             | - |     |                                                                   | - |     |                                                                                                     | - |     |                                                                                                                     | - |
| Michelle Yanez      |     |                                                                     |       - |     |                                                                       | 200,000 |     |                                                                                            | - |     | $                           | 5.02 |     |                        | 8/27/34 |     |                                                             | - |     |                                                                   | - |     |                                                                                                     | - |     |                                                                                                                     | - |
| Christopher Chapman |     |                                                                     |       - |     |                                                                       |       - |     |                                                                                            | - |     |                             |    - |     |                        |         |     |                                                             | - |     |                                                                   | - |     |                                                                                                     | - |     |                                                                                                                     | - |
| Nathen Fuentes      |     |                                                                     |       - |     |                                                                       |       - |     |                                                                                            | - |     |                             |    - |     |                        |         |     |                                                             | - |     |                                                                   | - |     |                                                                                                     | - |     |                                                                                                                     | - |

Option Exercises and Stock Vested

No stock options were exercised by our executive officers during the year ended December 31, 2024.

| ● | Erez                                                          
 Aminov, Chief Executive Officer and Chairman;                 |
| ● | Michelle                                                      
 Yanez, MBA, Chief Financial Officer, Secretary and Treasurer. |

Summary Compensation Table

The following table shows the compensation paid by us during the 2024 and 2023 fiscal years to our named executive officers.

| Name and principal position |     | Year |      |     | Salary ($) |         |     | Bonus ($) |         |    |     | Stock Awards ($) |         |    |     | Option Awards ($) (6) |           |     | Non-Equity Incentive Plan Compensation ($) |   |     | Nonqualified Deferred Compensation Earnings ($) |   |     | All Other Compensation ($) |        |    |     | Total ($) |           |
| Erez Aminov,                |     |      | 2024 |     |            | 259,999 |     |           | 300,000 | -1 |     |                  | 595,000 | -2 |     |                       |